Top Markets
Coin of the day
GemVax&KAEL Co.,Ltd GemVax&KAEL Co.,Ltd

GemVax&KAEL Co.,Ltd

082270
株式のランク #15778
GemVax & KAEL Co., Ltd. specializes in manufacturing chemical filtration... GemVax & KAEL Co., Ltd. specializes in manufacturing chemical filtration systems and gas purification units, primarily for the semiconductor industry. The company operates through two main segments: Environmental Pollution Control and Bio Business. Its Environmental Pollution Control division focuses on creating essential filters for semiconductor and display fabrication processes, in addition to developing equipment for air quality management and odor prevention. Concurrently, the Bio Business division is dedicated to advancing its innovative telomerase-derived peptide drug, GV1001, through preparations for domestic and international Phase 2 and 3 clinical trials. These trials are designed to address various conditions, including Alzheimer's disease, benign prostatic hyperplasia, and progressive supranuclear palsy. Founded on March 10, 1998, GemVax & KAEL Co., Ltd. is headquartered in Daejeon, South Korea.
株価
$7.54
時価総額
$331.60M
変化(1日)
-3.79%
変化(1年)
-75.66%
KR
取引 GemVax&KAEL Co.,Ltd (082270)

カテゴリー

GemVax&KAEL Co.,Ltd(082270)の配当利回りの履歴
GemVax&KAEL Co.,Ltd(銘柄コード: 082270)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
GemVax&KAEL Co.,Ltd(082270)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)